tiprankstipranks
CVS Health Corp (CH:CVS)
NYSE:CVS
Switzerland Market
CVS
CVS Health
RESEARCH TOOLSreports

CVS Health (CVS) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

CVS Analyst Ratings

Strong Buy
17Ratings
Strong Buy
17 Buy
0 Hold
0 Sell
Based on 17 analysts giving stock ratings to
CVS
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CVS Stock 12 Month Forecast

Average Price Target

$85.33
Based on 17 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $85.33 with a high forecast of $92.96 and a low forecast of $74.37. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$92.96Average Price Target$85.33Lowest Price Target$74.37
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on CH:CVS
Allen Lutz
Bank of America Securities
Bank of America Securities
CHF80.84→CHF88.92
Buy
―
Reiterated
06/22/26
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), Taysha Gene Therapies (NASDAQ: TSHA) and AbbVie (NYSE: ABBV)
Bernstein Analyst forecast on CH:CVS
Lance Wilkes
Bernstein
Bernstein
CHF85.69
Buy
―
Reiterated
06/09/26
Bernstein Remains a Buy on CVS Health (CVS)
Mizuho Securities Analyst forecast on CH:CVS
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF88.92→CHF92.96
Buy
―
Reiterated
06/08/26
CVS Health price target raised to $115 from $110 at MizuhoCVS Health price target raised to $115 from $110 at Mizuho
UBS Analyst forecast on CH:CVS
Kevin Caliendo
UBS
UBS
CHF80.84→CHF92.96
Buy
―
Reiterated
06/08/26
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (NASDAQ: SENS) and CVS Health (NYSE: CVS)
Morgan Stanley Analyst forecast on CH:CVS
Erin Wright
Morgan Stanley
Morgan Stanley
CHF85.69→CHF89.73
Buy
―
Reiterated
06/04/26
CVS Health price target raised to $111 from $106 at Morgan StanleyCVS Health price target raised to $111 from $106 at Morgan Stanley
Wells Fargo Analyst forecast on CH:CVS
Stephen Baxter
Wells Fargo
Wells Fargo
CHF83.26
Buy
―
Reiterated
06/04/26
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), TG Therapeutics (NASDAQ: TGTX) and Dexcom (NASDAQ: DXCM)
Truist Financial Analyst forecast on CH:CVS
David S Macdonald
Truist Financial
Truist Financial
CHF82.45→CHF87.31
Buy
―
Reiterated
06/01/26
CVS Health price target raised to $108 from $102 at TruistCVS Health price target raised to $108 from $102 at Truist
J.P. Morgan Analyst forecast on CH:CVS
Lisa Gill
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
05/27/26
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), Dexcom (NASDAQ: DXCM) and HCA Healthcare (NYSE: HCA)
Barclays Analyst forecast on CH:CVS
Andrew Mok CFA
Barclays
Barclays
CHF81.65→CHF85.69
Buy
―
Reiterated
05/26/26
CVS Health price target raised to $106 from $101 at BarclaysCVS Health price target raised to $106 from $101 at Barclays
Argus Research Analyst forecast on CH:CVS
Steven Silver
Argus Research
Argus Research
CHF72.75→CHF84.07
Buy
―
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), BioMarin Pharmaceutical (NASDAQ: BMRN) and AbbVie (NYSE: ABBV)
TD Cowen Analyst forecast on CH:CVS
Charles Rhyee
TD Cowen
TD Cowen
CHF84.88→CHF88.92
Buy
―
Reiterated
05/11/26
Analysts Conflicted on These Healthcare Names: Agilon Health (NYSE: AGL) and CVS Health (NYSE: CVS)
Deutsche Bank Analyst forecast on CH:CVS
George Hill
Deutsche Bank
Deutsche Bank
CHF71.14→CHF74.37
Buy
―
Reiterated
05/07/26
CVS Health price target raised to $92 from $88 at Deutsche BankCVS Health price target raised to $92 from $88 at Deutsche Bank
Goldman Sachs Analyst forecast on CH:CVS
Scott Fidel
Goldman Sachs
Goldman Sachs
CHF78.41→CHF84.07
Buy
―
Reiterated
05/07/26
CVS Health (CVS) Receives a Buy from Goldman Sachs
Evercore ISI Analyst forecast on CH:CVS
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF80.84→CHF84.88
Buy
―
Reiterated
05/07/26
CVS Health price target raised to $105 from $100 at Evercore ISICVS Health price target raised to $105 from $100 at Evercore ISI
RBC Capital Analyst forecast on CH:CVS
Ben Hendrix
RBC Capital
RBC Capital
CHF75.18→CHF86.5
Buy
―
Reiterated
05/06/26
RBC Capital Sticks to Their Buy Rating for CVS Health (CVS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on CH:CVS
Allen Lutz
Bank of America Securities
Bank of America Securities
CHF80.84→CHF88.92
Buy
―
Reiterated
06/22/26
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), Taysha Gene Therapies (NASDAQ: TSHA) and AbbVie (NYSE: ABBV)
Bernstein Analyst forecast on CH:CVS
Lance Wilkes
Bernstein
Bernstein
CHF85.69
Buy
―
Reiterated
06/09/26
Bernstein Remains a Buy on CVS Health (CVS)
Mizuho Securities Analyst forecast on CH:CVS
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF88.92→CHF92.96
Buy
―
Reiterated
06/08/26
CVS Health price target raised to $115 from $110 at MizuhoCVS Health price target raised to $115 from $110 at Mizuho
UBS Analyst forecast on CH:CVS
Kevin Caliendo
UBS
UBS
CHF80.84→CHF92.96
Buy
―
Reiterated
06/08/26
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (NASDAQ: SENS) and CVS Health (NYSE: CVS)
Morgan Stanley Analyst forecast on CH:CVS
Erin Wright
Morgan Stanley
Morgan Stanley
CHF85.69→CHF89.73
Buy
―
Reiterated
06/04/26
CVS Health price target raised to $111 from $106 at Morgan StanleyCVS Health price target raised to $111 from $106 at Morgan Stanley
Wells Fargo Analyst forecast on CH:CVS
Stephen Baxter
Wells Fargo
Wells Fargo
CHF83.26
Buy
―
Reiterated
06/04/26
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), TG Therapeutics (NASDAQ: TGTX) and Dexcom (NASDAQ: DXCM)
Truist Financial Analyst forecast on CH:CVS
David S Macdonald
Truist Financial
Truist Financial
CHF82.45→CHF87.31
Buy
―
Reiterated
06/01/26
CVS Health price target raised to $108 from $102 at TruistCVS Health price target raised to $108 from $102 at Truist
J.P. Morgan Analyst forecast on CH:CVS
Lisa Gill
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
05/27/26
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), Dexcom (NASDAQ: DXCM) and HCA Healthcare (NYSE: HCA)
Barclays Analyst forecast on CH:CVS
Andrew Mok CFA
Barclays
Barclays
CHF81.65→CHF85.69
Buy
―
Reiterated
05/26/26
CVS Health price target raised to $106 from $101 at BarclaysCVS Health price target raised to $106 from $101 at Barclays
Argus Research Analyst forecast on CH:CVS
Steven Silver
Argus Research
Argus Research
CHF72.75→CHF84.07
Buy
―
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), BioMarin Pharmaceutical (NASDAQ: BMRN) and AbbVie (NYSE: ABBV)
TD Cowen Analyst forecast on CH:CVS
Charles Rhyee
TD Cowen
TD Cowen
CHF84.88→CHF88.92
Buy
―
Reiterated
05/11/26
Analysts Conflicted on These Healthcare Names: Agilon Health (NYSE: AGL) and CVS Health (NYSE: CVS)
Deutsche Bank Analyst forecast on CH:CVS
George Hill
Deutsche Bank
Deutsche Bank
CHF71.14→CHF74.37
Buy
―
Reiterated
05/07/26
CVS Health price target raised to $92 from $88 at Deutsche BankCVS Health price target raised to $92 from $88 at Deutsche Bank
Goldman Sachs Analyst forecast on CH:CVS
Scott Fidel
Goldman Sachs
Goldman Sachs
CHF78.41→CHF84.07
Buy
―
Reiterated
05/07/26
CVS Health (CVS) Receives a Buy from Goldman Sachs
Evercore ISI Analyst forecast on CH:CVS
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF80.84→CHF84.88
Buy
―
Reiterated
05/07/26
CVS Health price target raised to $105 from $100 at Evercore ISICVS Health price target raised to $105 from $100 at Evercore ISI
RBC Capital Analyst forecast on CH:CVS
Ben Hendrix
RBC Capital
RBC Capital
CHF75.18→CHF86.5
Buy
―
Reiterated
05/06/26
RBC Capital Sticks to Their Buy Rating for CVS Health (CVS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CVS Health

3 Months
Elizabeth Anderson CFAEvercore ISI
Success Rate
16/24 ratings generated profit
67%
Average Return
+7.05%
Copying Elizabeth Anderson CFA's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +7.05% per trade.
1 Year
Erin WrightMorgan Stanley
Success Rate
16/21 ratings generated profit
76%
Average Return
+18.66%
Copying Erin Wright's trades and holding each position for 1 Year would result in 76.19% of your transactions generating a profit, with an average return of +18.66% per trade.
2 Years
Allen LutzBank of America Securities
Success Rate
24/24 ratings generated profit
100%
Average Return
+47.36%
Copying Allen Lutz's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +47.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CVS Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
34
21
22
34
39
Hold
7
5
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
41
26
23
34
39
In the current month, CVS has received 39 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CVS average Analyst price target in the past 3 months is 85.33.
Each month's total comprises the sum of three months' worth of ratings.

CVS Financial Forecast

CVS Earnings Forecast

Next quarter’s earnings estimate for CVS is $1.46 with a range of $1.18 to $1.64. The previous quarter’s EPS was $2.04. CVS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.
Next quarter’s earnings estimate for CVS is $1.46 with a range of $1.18 to $1.64. The previous quarter’s EPS was $2.04. CVS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.

CVS Sales Forecast

Next quarter’s sales forecast for CVS is $79.64B with a range of $77.45B to $83.46B. The previous quarter’s sales results were $79.85B. CVS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.
Next quarter’s sales forecast for CVS is $79.64B with a range of $77.45B to $83.46B. The previous quarter’s sales results were $79.85B. CVS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.

CVS Stock Forecast FAQ

What is CH:CVS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health Corp’s 12-month average price target is 85.33.
    What is CH:CVS’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:CVS, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is CVS Health Corp a Buy, Sell or Hold?
        CVS Health Corp has a consensus rating of Strong Buy, which is based on 17 buy ratings, 0 hold ratings and 0 sell ratings.
          What is CVS Health Corp’s share price target?
          The average share price target for CVS Health Corp is 85.33. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $92.96 ,and the lowest forecast is $74.37. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about CVS Health Corp?
            CVS Health Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
              How can I buy shares of CVS Health Corp?
              To buy shares of CH:CVS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.